Sarah Crunkhorn
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, CAR-T cell therapy research, Adipose Tissue and Metabolism, Protein Degradation and Inhibitors, Computational Drug Discovery Methods
Most-Cited Works
- → Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role ofPGC1andNRF1(2003)1,930 cited
- → Peroxisome Proliferator Activator Receptor γ Coactivator-1 Expression Is Reduced in Obesity(2007)234 cited
- → Expression of the Splicing Factor Gene SFRS10 Is Reduced in Human Obesity and Contributes to Enhanced Lipogenesis(2011)155 cited
- → Links between Thyroid Hormone Action, Oxidative Metabolism, and Diabetes Risk?(2008)140 cited
- → Abbott boosts investment in NRF2 activators for reducing oxidative stress(2012)71 cited
- → Dual modulation of both lipid oxidation and synthesis by peroxisome proliferator‐activated receptor‐γ coactivator‐1α and ‐1β in cultured myotubes(2009)58 cited
- → Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle(2006)54 cited
- → Targeting the mitochondria to block tumour growth(2021)34 cited
- → Gallium fights infection in phase I trial(2018)27 cited
- → Necdin and E2F4 Are Modulated by Rosiglitazone Therapy in Diabetic Human Adipose and Muscle Tissue(2006)24 cited